Riskpilot← Back to searchSign inGet full accessDC SciArt AB
ABActiveOrg 5592926017Matematikgränd 5 AVisual arts creation activities · NACE 9012Est. 20201 employees
Revenue 2025
SEK 360K
-25% vs 2024
EBITDA margin
-4.6%
+62% vs 2024
Equity ratio
75.0%
Financial strength
Net profit 2025
SEK -16K
+34% vs 2024
| Revenue | SEK 360K | -25% |
| EBITDA | SEK -16K | +62% |
| Net profit | SEK -16K | +34% |
| Total assets | SEK 115K | +9% |
| Equity | SEK 86K | -16% |
| Employees | 1 | — |
Legal name
DC SciArt AB
Org number
5592926017
Legal form
Aktiebolag
NACE code
9012 · Visual arts creation activities
Founded
21 december 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska producera och sälja vetenskapliga och tecknade illustrationer, konsultera, föreläsa och anordna workshops inom kommunikation och däremot förenlig verksamhet.
Address
Matematikgränd 5 A
Email
dariach212@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 340 | 601 | 529 | 481 | 360 |
| Staff expenses | — | −418 | −457 | −312 | −296 |
| EBITDA | 63 | 75 | 10 | −44 | −16 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 63 | 75 | 10 | −44 | −16 |
| Net financials | — | 0 | 0 | 0 | 0 |
| Profit before tax | 63 | 56 | 11 | −25 | −16 |
| Tax | −14 | −12 | −2 | −2 | — |
| Net profit | 49 | 45 | 9 | −25 | −16 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 122 | 173 | 194 | 106 | 115 |
| Equity | 74 | 119 | 128 | 103 | 86 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 47 | 35 | 48 | 3 | 29 |
| Total debt | 47 | 35 | 48 | 3 | 29 |
EBITDA margin
-4.6%
This company
15.8%
Market median
-129% vs market
20212025
Equity ratio
75.0%
This company
38.2%
Market median
+96% vs market
20212025
Return on equity
-19.0%
This company
18.4%
Market median
-203% vs market
20212025
Net profit margin
-4.6%
This company
8.1%
Market median
-157% vs market
20212025
Asset turnover
3.13×
This company
1.12×
Market median
+179% vs market
20212025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DC SciArt AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Yvette Chrobok | Deputy Board Member | 0 companies |
| Regina Margarethe Gratz | Deputy Board Member | 0 companies |
| Daria Anna Chrobok | Board of Directors | 0 companies |